Relevant conflict of interest/financial disclosure: ARB received research grants by Ipsen, the manufacturer of Dysport. Other authors have no conflict of interest. Full financial disclosure and author roles can be found in the online version of this article.
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease†
Article first published online: 21 JAN 2011
Copyright © 2010 Movement Disorder Society
Volume 26, Issue 2, pages 313–319, 1 February 2011
How to Cite
Guidubaldi, A., Fasano, A., Ialongo, T., Piano, C., Pompili, M., Mascianà, R., Siciliani, L., Sabatelli, M. and Bentivoglio, A. R. (2011), Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. Mov. Disord., 26: 313–319. doi: 10.1002/mds.23473
- Issue published online: 14 MAR 2011
- Article first published online: 21 JAN 2011
- Manuscript Received: 29 SEP 2010
- Manuscript Accepted: 13 SEP 2010
- Manuscript Revised: 11 MAR 2010
Additional Supporting Information may be found in the online version of this article.
|MDS_23473_sm_supptableA.doc||99K||Supporting Table A.|
|MDS_23473_sm_authorroles.doc||74K||Author Roles and Disclosures|
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.